Mevalonic acid analogs as inhibitors of cholesterol biosynthesis. 1981

C R DeBold, and J C Elwood
Department of Biochemistry, State University of New York, Upstate Medical Center, Syracuse 13210.

A series of 20 mevalonic acid analogs was synthesized and tested for their ability to inhibit cholesterol biosynthesis from [2-14C]-mevalonate in rat liver homogenates. Removal of the 5-hydroxyl group from mevalonic acid produced an active inhibitor, 3-hydroxy-3-methylpentanoic acid. Removal of the 3-hydroxyl group, addition of an aromatic group in the 3-position, or insertion of a double bond reduced inhibitory activity. Compounds with an aromatic group or halide on the 5-position were active inhibitors. The most active inhibitor was 5-phenylpentanoic acid, with 50% inhibition at 0.064 mM.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008798 Mevalonic Acid A dihydroxy monocarboxylic acid and precursor in the biosynthetic pathway known as the mevalonate pathway, which produces terpenes and steroids that are vital for diverse cellular functions. Mevalonate,Acid, Mevalonic
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000924 Anticholesteremic Agents Substances used to lower plasma CHOLESTEROL levels. Cholesterol Inhibitors,Hypocholesteremic Agents,Anticholesteremic Drugs,Anticholesteremics,Inhibitors, Cholesterol,Agents, Anticholesteremic,Agents, Hypocholesteremic,Drugs, Anticholesteremic
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

C R DeBold, and J C Elwood
January 1971, Biokhimiia (Moscow, Russia),
C R DeBold, and J C Elwood
April 1962, The American journal of clinical nutrition,
C R DeBold, and J C Elwood
April 1964, Science (New York, N.Y.),
C R DeBold, and J C Elwood
January 1999, Critical reviews in biochemistry and molecular biology,
C R DeBold, and J C Elwood
April 1959, Proceedings of the National Academy of Sciences of the United States of America,
C R DeBold, and J C Elwood
October 1985, Clinica chimica acta; international journal of clinical chemistry,
C R DeBold, and J C Elwood
May 1975, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
C R DeBold, and J C Elwood
October 1996, Journal of lipid research,
C R DeBold, and J C Elwood
January 1965, Journal of bacteriology,
C R DeBold, and J C Elwood
January 1971, Acta chemica Scandinavica,
Copied contents to your clipboard!